Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Prospective Evaluation of Silk Fibroin Incision Dressings in ACL Reconstruction

NCT: NCT07217613 · RECRUITING

NCT IDNCT07217613
StatusRECRUITING
Start Date2025-10-14
Completion2026-07

Brief Summary

The purpose of this study is to compare the incidence of early postoperative skin complications including allergic contact dermatitis, blistering, and erythema between silk fibroin incision dressings and cyanoacrylate closure in patients undergoing anterior cruciate ligament reconstruction.

Frequently Asked Questions

What is Prospective Evaluation of Silk Fibroin Incision Dressings in ACL Reconstruction?

Prospective Evaluation of Silk Fibroin Incision Dressings in ACL Reconstruction is a clinical trial registered under NCT07217613. Current status: RECRUITING.

What is the status of NCT07217613?

The current status of NCT07217613 (Prospective Evaluation of Silk Fibroin Incision Dressings in ACL Reconstruction) is: RECRUITING.

When did Prospective Evaluation of Silk Fibroin Incision Dressings in ACL Reconstruction start?

Prospective Evaluation of Silk Fibroin Incision Dressings in ACL Reconstruction started on 2025-10-14.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑